America February 6, 2024
Novartis to Buy MorphoSys In €2.7B Deal
In a strategic move to bolster its oncology treatment options, Novartis AG, the Swiss pharmaceutical juggernaut, has inked a monumental…
America February 6, 2024
In a strategic move to bolster its oncology treatment options, Novartis AG, the Swiss pharmaceutical juggernaut, has inked a monumental…
By Rihem Akkouche